HomeDatabaseInsulin › Insulin — NPH
Insulin

Insulin — NPH — Half-Life, Dosing & Protocol Guide

Also known as: Humulin N, Novolin N, Isophane insulin, NPH insulin

FDA-Approved · FDA NDA 018781 (Humulin N prescribing information)
Plasma Half-Life
Onset 1–3h; peak 4–12h; duration up to 24h
Source: FDA NDA 018781 (Humulin N prescribing information)
Route
Subcutaneous only (never IV)
Frequency
1–2× daily
Dose Range
0.1–0.5 U/kg SC 1–2×/day
Category
Insulin

Pharmacokinetics & Mechanism

NPH insulin (Neutral Protamine Hagedorn — Humulin N/Novolin N) is human insulin co-crystallised with protamine and zinc. The crystalline depot dissolves slowly after subcutaneous injection: onset 1–3 hours, peak effect 4–12 hours, duration up to 24 hours (per FDA NDA 018781). The pronounced 4–12h peak creates a nocturnal hypoglycaemia risk when dosed at bedtime. Must never be administered intravenously. Cannot be mixed with insulin analogs (lispro, aspart) due to protamine interactions affecting absorption profiles.

Track Insulin — NPH in Halflife

The Halflife app models your Insulin — NPH concentration curve in real time — see exactly when your dose peaks, when it troughs, and how it overlaps with other compounds in your stack. All stored on-device, no account required.

See your Insulin — NPH curve live

Real-time pharmacokinetic model · Free iOS app

Download on App Store
See also: Full technical profile → All 45 compounds About the app